SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations

SGLT2i (sodium glucose transporter type 2 inhibitors) are pharmacological agents that act by inhibiting the SGLT2, by reducing the renal plasma glucose threshold and inducing glycosuria, resulting in a blood glucose lowering effect. In recent years, studies demonstrating some additional positive eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Maffei, Pietro, Bettini, Silvia, Busetto, Luca, Dassie, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642354/
https://www.ncbi.nlm.nih.gov/pubmed/37964939
http://dx.doi.org/10.2147/DMSO.S240903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642354/
https://www.ncbi.nlm.nih.gov/pubmed/37964939
http://dx.doi.org/10.2147/DMSO.S240903

Ejemplares similares